Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Abeona Therapeutics (ABEO) Inventory (2025)

Abeona Therapeutics has reported Inventory over the past 4 years, most recently at $5.5 million for Q4 2025.

For Q4 2025, Inventory changed N/A year-over-year to $5.5 million; the TTM value through Dec 2025 reached $5.5 million, changed N/A, while the annual FY2025 figure was $5.5 million, N/A changed from the prior year.
Inventory for Q4 2025 was $5.5 million at Abeona Therapeutics, up from $4.8 million in the prior quarter.
Over five years, Inventory peaked at $5.5 million in Q4 2025 and troughed at $2.7 million in Q2 2025.